A recent study clearly explains how a particular diabetes drug class ups the risk of people with diabetes developing heart problems . The drug class, Thiazolidinediones, have been in the media spotlight since Avandia (rosiglitazone), a GlaxoSmithKline drug was linked with greater heart attack risk.
A team at Washington University School of Medicine in St Louis, Missouri found a particular molecule that is activated by the diabetic drugs and could cause heart failure . Clay Semenkovich, an endocrinologist, reportedly commented: “We already knew if you had heart failure you probably should not be taking these drugs, but this paper provides an additional explanation why.”
The discovery was made accidentally as a team investigated what happens when tissues enlarge. The results of the diabetes study were published in the June Issue of Cell Metabolism.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…